Yatharth Hospitals acquires 60% stake in 400-bedded hospital in Faridabad for Rs. 91 Cr

Dr. Reddy’s Laboratories Switzerland incorporates a subsidiary in Denmark

he company will focus on production of any pharmaceutical and biotechnological products

Sun Pharma presents clinical efficacy and safety data in severe dermatological conditions at 2024 EADV Congress

The company will also share results in two additional posters for deuruxolitinib

Biocon Biologics announces new dermatology data to be presented at EADV Congress 2024

These clinical studies support the interchangeability of adalimumab-fkjp at low-concentration with high-concentration adalimumab and ustekinumab biosimilarity

Wockhardt's Zaynich cures complex case of meningitis caused by pan-drug resistant super-bug under compassionate use

A multi-disciplinary team of senior physicians opted to use Zidebactam/Cefepime under compassionate use

Beiersdorf and Macro Biologics announce partnership to develop antimicrobial peptides

Multi-year collaboration focuses on development of biodegradable antimicrobial peptides with broad application possibilities in the areas of skin care and healthcare

DKSH partners with Hasten Biopharmaceutical’s growth in Thailand

Mangalam Drugs & Organics expanding anti-malaria APl portfolio with introduction of Pyronaridine

This development will position the company at the forefront of anti- malaria API production globally and is expected to drive substantial growth and profitability

Fortis Hospital Mulund hosts India's first IFEM endorsed ECMO workshop for emergency medicine doctors

This two-day program was attended by 40 doctors & paramedical staff

Indian API companies to grow by 7-8% and operating profit margin to improve to 12-14% in FY2025: ICRA

Capital expenditure expected to moderate to Rs. 5.6 billion in FY2025 from an estimated Rs. 7.6 billion in FY2024